Nurse Practitioner, Pediatrics · Orlando, FL
NPI
1497230031
Since 2018
Specialty
Nurse Practitioner, Pediatrics
Code 363LP0200X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
92 W Miller St
Orlando, FL, 32806
Phone (321) 841-8588
Groups this clinician bills Medicare through
Medicare paid, 2024
$10K
197 services
Medicare patients, 2024
80
Average age 70
Drug cost, 2024
$3.5M
1,738 prescriptions
Company payments, 2025
$124
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Melissa F Morris was code 99214 (office e&m - established), 135 times for 42 patients. In total Melissa F Morris billed 197 services in 5 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 135 | 42 | $56.93 | $7,686 |
| 99213 Office E&M - Established | Facility | 47 | 37 | $38.08 | $1,790 |
By year: 2022 $12K for 228 services; 2023 $16K for 291 services; 2024 $10K for 197 services.
Medicare prescription drug claims, 2024
In 2024, the drug Melissa F Morris prescribed most often to Medicare patients was Letrozole, with 280 prescriptions and refills. In total Melissa F Morris wrote 1,738 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 280 | 586 | 66 | $3,843 |
| Anastrozole Generic | 211 | 422 | 61 | $2,482 |
| Gabapentin Generic | 94 | 100 | 19 | $1,124 |
| Exemestane Generic | 82 | 154 | 25 | $9,888 |
| Ondansetron Hcl Generic | 71 | 71 | 34 | $390 |
| Levothyroxine Sodium Generic | 67 | 67 | Under 11 | $473 |
| Verzenio Abemaciclib | 65 | 65 | 13 | $921K |
| Prednisone Generic | 64 | 64 | 21 | $156 |
| Tamoxifen Citrate Generic | 47 | 76 | 12 | $514 |
| Prochlorperazine Maleate Generic | 44 | 44 | 30 | $491 |
| Abiraterone Acetate Generic | 36 | 36 | Under 11 | $21K |
| Xtandi Enzalutamide | 32 | 32 | Under 11 | $365K |
| Erleada Apalutamide | 25 | 30 | Under 11 | $351K |
| Ibrance Palbociclib | 24 | 24 | Under 11 | $356K |
| Lynparza Olaparib | 23 | 23 | Under 11 | $180K |
Brand drugs: 335 claims; generic drugs: 1,403 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melissa F Morris $124 ($124 in general payments such as food, travel and fees) from 1 company. The largest payer was Merck Sharp & Dohme LLC with $124.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 1 | $124 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.